STABLE PHARMACEUTICAL COMPOSITION COMPRISING CARBETOCIN AND SUITABLE FOR VAGINAL ADMINISTRATION, AND PREPARATION METHOD THEREFOR
A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5% of an amino acid anionic surfactant, 0.1%-5% of a humectant, and the balance of water. The amino acid anionic surfactant in the pharmaceutical...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
28.06.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5% of an amino acid anionic surfactant, 0.1%-5% of a humectant, and the balance of water. The amino acid anionic surfactant in the pharmaceutical composition can effectively eliminate the clinical difference caused by the individual difference, can effectively and stably stimulate uterine contraction, and can maintain the stability of a drug.
L'invention concerne une composition pharmaceutique comprenant de la carbétocine, comprenant (pour cent en poids) : 0,5 % à 7 % de carbétocine, 1 % à 10 % d'un matériau de matrice soluble dans l'eau, 0,5 % à 5 % d'un tensioactif anionique d'acide aminé, 0,1 % à 5 % d'un humectant, et le reste d'eau. Le tensioactif anionique d'acide aminé dans la composition pharmaceutique peut éliminer efficacement la différence clinique provoquée par la différence individuelle, peut stimuler efficacement et de manière stable la contra |
---|---|
AbstractList | A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5% of an amino acid anionic surfactant, 0.1%-5% of a humectant, and the balance of water. The amino acid anionic surfactant in the pharmaceutical composition can effectively eliminate the clinical difference caused by the individual difference, can effectively and stably stimulate uterine contraction, and can maintain the stability of a drug.
L'invention concerne une composition pharmaceutique comprenant de la carbétocine, comprenant (pour cent en poids) : 0,5 % à 7 % de carbétocine, 1 % à 10 % d'un matériau de matrice soluble dans l'eau, 0,5 % à 5 % d'un tensioactif anionique d'acide aminé, 0,1 % à 5 % d'un humectant, et le reste d'eau. Le tensioactif anionique d'acide aminé dans la composition pharmaceutique peut éliminer efficacement la différence clinique provoquée par la différence individuelle, peut stimuler efficacement et de manière stable la contra |
Author | TAO, An Jin LIN, Hao Wen YUAN, Jian Cheng ZHENG, Chun Lian LING, Ru Guang |
Author_xml | – fullname: LIN, Hao Wen – fullname: TAO, An Jin – fullname: LING, Ru Guang – fullname: YUAN, Jian Cheng – fullname: ZHENG, Chun Lian |
BookMark | eNqNy00OgjAUBOAudOHfHZq41cTCQrePUuhLoG3aoktCTF0ZIMEDeHQRPICrmUzmW5NF27VhRd7OQ1IIaiTYErioPHIoKNel0Q49ajV1iw5VTjnYRHjNUVFQKXUVzjrTll4hRzVSSEtU6LyFrz5MR2OFgXmgpfBSp9RLYcXotmT5aJ5D2P1yQ_aZ8FweQ9_VYeibe2jDq77p6MQujMXROQYW__f6ACqHPzM |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSITION PHARMACEUTIQUE STABLE COMPRENANT DE LA CARBÉTOCINE ET APPROPRIÉE POUR UNE ADMINISTRATION VAGINALE, ET SON PROCÉDÉ DE PRÉPARATION 一种稳定的含卡贝缩宫素的阴道给药的药用组合物及其制备方法 |
ExternalDocumentID | WO2018113273A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2018113273A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 16:00:22 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2018113273A13 |
Notes | Application Number: WO2017CN92718 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180628&DB=EPODOC&CC=WO&NR=2018113273A1 |
ParticipantIDs | epo_espacenet_WO2018113273A1 |
PublicationCentury | 2000 |
PublicationDate | 20180628 |
PublicationDateYYYYMMDD | 2018-06-28 |
PublicationDate_xml | – month: 06 year: 2018 text: 20180628 day: 28 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | HYBIO PHARMACEUTICAL CO., LTD |
RelatedCompanies_xml | – name: HYBIO PHARMACEUTICAL CO., LTD |
Score | 3.2718074 |
Snippet | A pharmaceutical composition comprising carbetocin, comprising (percent by weight): 0.5%-7% of carbetocin, 1%-10% of a water-soluble matrix material, 0.5%-5%... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | STABLE PHARMACEUTICAL COMPOSITION COMPRISING CARBETOCIN AND SUITABLE FOR VAGINAL ADMINISTRATION, AND PREPARATION METHOD THEREFOR |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180628&DB=EPODOC&locale=&CC=WO&NR=2018113273A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkDpk8V9dFv7MCRNszViP2i7ubfRdB0Ksg1XEXzyT_eSberT3i4fF7iEy-WX5O4Qup0Isyms1NTBNme6IcxUT7NGS7dqrUlD5lwVQkX79NvuwHgctUYl9LbxhVFxQj9VcETQqAz0vVD79eLvEstRfyuX9-IVquYPvaTraGt0XDelS6Dm2F0WBk5ANUoBt2l-pNpkUvVOkwBW2oGDdEfqAxva0i9l8d-o9A7RbgjjzYojVPp6qaB9usm9VkF73vrJG8i19i2P0XecEPuJ4dAlkUcoGyQymAGmgRcGMZd3TYqOeMz9PqYkslkSUO5j4js4HvAVN8A-PCR97gMrcTzuc5k3WXLfqY6wJiFZVWCPJW7g4MRlEQO-E3TTYwl1dRBl_Dtz4-fgv9zNU1SezWf5GcJTQDmNdmbmqWEZqZVZmUhrRt3McyPLpjXrHFW3jXSxvfkSHcii_FHVMKuoXLx_5Fdguwtxrab8BzNNk6Q |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG-IGvFNUeMHahPNnlyEMWB7IKbrCquyj4yCvJF1jGhigMiMiU_-6bYFlCfemrveJW1zvf7a3h0Ad2Nu1bidWLrwzalucivRk9So63alPjZkzVXOVbbPoOH1zadhfVgA7-tYGJUn9EslRxQWlQp7z9V-Pf-_xHLV38rFA38TpNljm7VcbYWOq5YMCdRcp0Wi0A2xhrHAbVoQK54sqt6sIYGVdsUhuyntgQwcGZcy33Qq7UOwFwl90_wIFL5fS6CI17XXSmDfXz15i-bK-hbH4KfHkNMlMPJQ7CNM-kwmM4A49KOwR-Vdk2rHtEeDDsQodggLMQ0gClzY69OltIB9cIA6NBCiyPVpQGXdZCl9rzqKNYnQkgB9wrzQhcwjMRFyJ-C2TRj2dDGU0d_MjV7CzXHXTsHOdDbNzgCcCJRjNFIrS0zbTOzUTnlSMatWlplpOqnY56C8TdPFdvYNKHrM7466NHi-BAeSJX9XGVYZ7OQfn9mV8OM5v1bT_wtNe5aX |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABLE+PHARMACEUTICAL+COMPOSITION+COMPRISING+CARBETOCIN+AND+SUITABLE+FOR+VAGINAL+ADMINISTRATION%2C+AND+PREPARATION+METHOD+THEREFOR&rft.inventor=LIN%2C+Hao+Wen&rft.inventor=TAO%2C+An+Jin&rft.inventor=LING%2C+Ru+Guang&rft.inventor=YUAN%2C+Jian+Cheng&rft.inventor=ZHENG%2C+Chun+Lian&rft.date=2018-06-28&rft.externalDBID=A1&rft.externalDocID=WO2018113273A1 |